CASS4 is a genetic risk factor for #Alzheimers disease but remains understudied in the brain. Walsh, @LukensJohnR et al. identify CASS4 as a critical regulator of amyloid β plaque compaction, microglial mobilization to damage, & focal adhesion signaling. https://t.co/12MBCGw3bO
New study from our group @Addie_E_Walsh 👇
Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis @JExpMed https://t.co/v6woVm7AYG #Alzheimer
My first-author paper is now live @JExpMed! We found that the Alzheimer's disease risk factor CASS4 is a critical regulator of amyloid beta plaque compaction, microglial mobilization to damage, and focal adhesion signaling.
https://t.co/ZiR1fbd6Xf
Excited to be attending the @KeystoneSymp on Neuroinflammation in Health and Disease next week! I'll be presenting a poster and am looking forward to hearing a short talk from my lab mate @sydney_labuzan and from our neighbors in the Lukens lab, @Addie_E_Walsh ⭐️
John Lukens and his team @UVA have discovered how traumatic brain injury increases Alzheimer's risk—and found a way to potentially prevent it.
Learn more: https://t.co/jTHklSOBw7
Dear colleagues, do you know anyone working at one of the national labs who might be willing to give a career development seminar at UVA in the spring? It's not guaranteed this event will happen, I just want to establish contact now. All travel expenses would be paid for. Thanks.
🔬 Exciting Opportunity Alert!
Join the Lukens Lab at @UVA to explore immune contributions to Alzheimer’s & neurodegenerative diseases.
@LukensJohnR is seeking a Senior Staff Scientist - truly one of the best opportunities in the field!
Apply now:
https://t.co/drcbxy02N6
Associate professor of neuroscience John Lukens, PhD, received a $2.8 million @NIH grant for a project studying an #Alzheimers gene. These findings will help identify how to better target the gene as a therapeutic strategy. @LukensJohnR#AlzheimersResearch https://t.co/w98kSUi3IO
Associate professor of neuroscience John Lukens, PhD, received a $2.8 million @NIH grant for a project studying an #Alzheimers gene. These findings will help identify how to better target the gene as a therapeutic strategy. @LukensJohnR#AlzheimersResearch https://t.co/w98kSUi3IO
Innovative Alzheimer's researcher John Lukens, PhD, named inaugural director of UVA’s Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases, part of the Paul and Diane Manning Institute. @LukensJohnR@uvahealthnews https://t.co/p5qXK5GIre